CARDIOTOXICITY

This study tested whether a supervised aerobic exercise program could improve heart health in childhood cancer survivors. The participants, who had received a specific type of chemotherapy that can damage the heart, followed a 12-week exercise plan. Researchers measured changes i…

This study tested whether a diabetes drug called dapagliflozin could protect the heart in cancer patients receiving a common but potentially heart-damaging chemotherapy. 90 patients were randomly assigned to take either dapagliflozin or a placebo pill daily for four months alongs…

This study tested if giving a heart medication called carvedilol to breast cancer patients at higher risk of heart damage could protect their hearts during chemotherapy. It involved 68 women receiving specific cancer drugs (doxorubicin and/or trastuzumab). The goal was to see if …

This pilot study tested whether a special exercise and lifestyle program is practical and safe for young cancer survivors who are at risk for heart problems. It involved 30 survivors aged 18-45 who had finished cancer treatment but had early signs of mild heart dysfunction. The m…

This study aims to understand how two different types of radiation therapy affect the heart in breast cancer patients. Researchers followed 172 patients who were already enrolled in a larger radiation comparison trial. They measured heart function and collected blood samples befo…

This study aimed to find better ways to detect early heart damage caused by breast cancer treatments like chemotherapy and radiation. Researchers followed 150 patients for up to 10 years, using special heart scans and blood tests to look for early warning signs. The goal was to l…

This study aimed to understand how CAR-T cell therapy, a powerful cancer treatment, affects the heart. Researchers followed 44 adults with leukemia or lymphoma, checking their heart function with scans and blood tests before and after treatment. The goal was to learn how often he…

This study aimed to understand how often a specific type of heart problem occurs in people with advanced lung cancer who are taking targeted drugs called EGFR-TKIs. Researchers followed 100 patients to monitor their heart function before and during treatment. The goal was to gath…